Pharma 5 presented an epilepsy medicine made from Moroccan legally grown cannabis at the CPHI pharmaceutical exhibition in Milan, held from 6 to 8 October. The company called it Morocco's first locally produced cannabis-based medicine. Sothema had already obtained marketing authorisation for three other cannabis-based epilepsy medicines, and five Moroccan medical societies had approved protocols for prescribing CBD. The products sit under the 2021 cannabis law and the pharmaceutical code (Law 17-04).[1]
Listed for context. No score change is recorded for Morocco here.
References
- Hespress English — Moroccan pharmaceutical firm unveils first locally produced medical cannabis drug at global expo in Milan (13 October 2026)Pharma 5 product at CPHI Milan, Sothema's three authorised epilepsy medicines and the five prescribing protocols
Checked. The date and the event were compared with a source that was read.